News
Pan-cancer AI tool boosts immunotherapy prediction accuracy
1+ hour, 40+ min ago (10+ words) First Word Pharma...
Symbols: path-io,nasdaq:gtbp,nasdaq:cai
Friday Five " Top-line takeaways, Medicare bridges GLP-1 coverage gap, Ipsen's specialty deal duo'and more
14+ hour, 52+ min ago (19+ words) First Word Pharma...
Symbols: shop.to,cco.to,gal.ne,aisx.v,cans.v,vti.cn
Biopharma bites: Otsuka's long-term Voyxact data, United takes out Thymmune, and more from Junshi, Novartis, Arcturus
19+ hour, 37+ min ago (19+ words) First Word Pharma...
Symbols: otcmkts:otsky,nyse:lly,btc-usd,nyse:nvo
Pure Tech helps pump $180 M into pulmonary disease spinoff Celea
1+ day, 27+ min ago (11+ words) First Word PHARMA...
Symbols: btc-usd,lse:prtc
Roche's divarasib bests KRAS G12 C rivals in late-stage NSCLC study
1+ day, 4+ hour ago (13+ words) First Word Pharma...
Symbols: nasdaq:rvmd
Biopharma bites: Casgevy wins paediatric FDA approval, and more from Merck & Co. , Angitia, Idorsia
1+ day, 17+ hour ago (17+ words) First Word Pharma...
Symbols: nyse:mrk
Physician Views Preview: Medicare builds GLP-1 bridge, but are doctors ready to cross it?
1+ day, 21+ hour ago (17+ words) First Word Pharma...
Symbols: btc-usd
Can-Fite posts positive mid-stage data for oral drug in pancreatic cancer
2+ day, 3+ hour ago (15+ words) First Word Pharma...
Symbols: btc-usd
Physician Views Preview: Abivax seeks to allay safety concerns as it readies potential first-in-class ulcerative colitis therapy for regulatory submission
2+ day, 4+ hour ago (24+ words) First Word Pharma...
Symbols: nyse:abbv
Alze Cure surges on another heavily backloaded Alzheimer's drug development deal
2+ day, 6+ hour ago (12+ words) First Word Pharma...
Symbols: nasdaq:axsm,alzcur.st,btc-usd